Study Stopped
grant was not approved.
Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism
1 other identifier
observational
200
1 country
1
Brief Summary
Individuals with Autism Spectrum Disorder will have abnormal DESA® results. Our objective is to use neuroelectrical measures to determine the degree of processing abnormalities in individuals with Autism. The study will survey processing patterns and will locate and evaluate the degree(s) of abnormalities for further study. The abnormal results of comprehensive neuroelectrical evaluations of individuals with Autism when compared to the normative database will provide objective, verifiable, neurophysiological information with which to form novel approaches to the disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2008
CompletedFirst Posted
Study publicly available on registry
June 9, 2008
CompletedStudy Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedOctober 2, 2009
October 1, 2009
1 year
June 5, 2008
October 1, 2009
Conditions
Keywords
Study Arms (2)
1
Year one
2
Year two
Eligibility Criteria
The study population includes individuals with Autism without exclusion on the basis of sex, gender, race or ethnicity. There will be 100 research subjects, with a ratio of four males to one female, and those being approximately sixty-five children and thirty-five adults.
You may qualify if:
- The study will include children between the ages of five and eighteen, adults from the age of nineteen to twenty-five, and those with the diagnosis of Autism and Autism Spectrum Disorders.
You may not qualify if:
- those with mental retardation
- those with any other neurological disorder
- those that cannot sit in a chair for one hundred and fifty minutes
- those that have been previously diagnosed with a seizure disorder
- those who are blind and/or deaf
- those who are not ambulatory
- those who cannot understand English
- those that are not a resident of Los Angeles County
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yellen & Associates, Inc.
Northridge, California, 91326, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew G Yellen, PhD
President, Yellen & Associates, Inc.
- STUDY CHAIR
Thomas Schweller, MD
Neurologist
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 5, 2008
First Posted
June 9, 2008
Study Start
January 1, 2010
Primary Completion
January 1, 2011
Study Completion
December 1, 2012
Last Updated
October 2, 2009
Record last verified: 2009-10